Brad Duft
No video provider was found to handle the given URL. See the documentation for more information.
Andrew Patterson meets a kiwi bio-tech company which has raised $74 million developing a therapeutic drug here for international markets
Andrew Patterson meets a kiwi bio-tech company which has raised $74 million developing a therapeutic drug here for international markets